Product image of Lindynette 30 (Ethinylestradiol, Gestodene) supplied by GNH India

Lindynette 30

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Lindynette 30 (Ethinylestradiol, Gestodene)

Ethinylestradiol, the active ingredient in Lindynette 30, is a combined oral contraceptive presented as a 30 µg ethinylestradiol / 0.075 mg gestodene oral tablet for oral use. It is a hormonal contraceptive indicated for the prevention of pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus and endometrial lining.

GNH India supplies Lindynette 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Lindynette 30 is a combined oral contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy and can also be used for related hormonal conditions.
  • Contraception: provides reliable prevention of pregnancy in women of childbearing potential.
  • Acne vulgaris: helps reduce inflammatory lesions and improve skin appearance.
  • Menstrual disorders: can regulate cycle length and reduce dysmenorrhea.

How It Works

  • Ethinylestradiol (estrogen) and gestodene (progestogen) suppress the hypothalamic‑pituitary‑ovarian axis, preventing the mid‑cycle luteinising hormone surge and thereby inhibiting follicular development and ovulation. The progestogen component also thickens cervical mucus and induces endometrial changes that reduce the likelihood of fertilisation and implantation.

Side Effects

Lindynette 30 may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects

  • Nausea
  • Breast tenderness
  • Headache
  • Weight gain or fluid retention
  • Mood changes
  • Breakthrough or spotting bleeding

Serious or Rare Side Effects

  • Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism)
  • Arterial thrombosis (stroke, myocardial infarction)
  • Hypertension or worsening of existing hypertension
  • Hepatic adenoma or other liver disorders
  • Gallbladder disease (cholestasis, gallstones)
  • Severe allergic reactions (anaphylaxis, angioedema)

Precautions & Warnings

Before prescribing Lindynette 30, clinicians should evaluate individual risk factors and contraindications.

  • Contraindications: known thrombogenic disorders, estrogen‑dependent tumors, active liver disease, pregnancy, breastfeeding.
  • Smoking: avoid use in women over 35 who smoke due to increased cardiovascular risk.
  • Cardiovascular risk: assess history of hypertension, stroke, or myocardial infarction before initiation.
  • Drug interactions: review concomitant medications that may induce hepatic enzymes or affect hormone levels.
  • Regular monitoring: check blood pressure and lipid profile periodically, especially in high‑risk patients.
  • Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and light.

Avoid Interactions

Lindynette 30 can interact with several medicines that alter hormone metabolism or increase thrombotic risk.

Major Interactions (Avoid)

  • Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive efficacy.
  • Rifampicin: decreases hormone levels, increasing risk of unintended pregnancy.
  • Protease inhibitors (e.g., ritonavir): may raise hormone concentrations and heighten side‑effect risk.

Moderate Interactions (Monitor Closely)

  • Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone levels.
  • St. John’s wort: may lower contraceptive effectiveness.
  • Certain antibiotics (e.g., tetracycline, metronidazole): generally minimal effect but require monitoring for breakthrough bleeding.

Frequently Asked Questions

Lindynette 30 is a combined oral contraceptive indicated for reliable prevention of pregnancy in women of reproductive age. It is also prescribed to help regulate menstrual cycles and to improve moderate acne by leveraging its hormonal effects.

Ethinylestradiol provides estrogenic activity while gestodene acts as a progestogen. Together they suppress the hypothalamic‑pituitary‑ovarian axis, preventing the luteinising hormone surge and ovulation. The progestogen also thickens cervical mucus and modifies the endometrium, creating an environment unfavorable for fertilisation and implantation.

The dosing regimen for Lindynette 30 is determined by the prescribing healthcare professional. Typically, it involves taking one tablet daily at the same time each day, but the exact schedule and any missed‑dose instructions are set by the prescriber.

Lindynette 30 is classified as pregnancy category X, meaning it is contraindicated in pregnancy because it may harm the fetus. It is also not recommended for breastfeeding women, as hormonal exposure can affect milk production and infant health.

To order Lindynette 30, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lindynette 30 offers comparable contraceptive efficacy to other combined oral contraceptives. Its specific progestogen, gestodene, is a third‑generation agent associated with a lower incidence of androgenic side effects such as acne, while maintaining similar protection against pregnancy. Safety and tolerability profiles may differ slightly based on individual patient factors.

Lindynette 30 tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct light, and store out of reach of children.

Lindynette 30 is taken orally as a single tablet each day, preferably at the same time each day. It can be taken with or without food. Consistent daily intake ensures optimal suppression of ovulation and maintains contraceptive effectiveness.

The most serious risks include venous thromboembolism (deep‑vein thrombosis, pulmonary embolism), arterial thrombosis (stroke, myocardial infarction), severe hypertension, hepatic adenoma or other liver disorders, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms suggestive of these conditions.

Lindynette 30 should not be used by women with a history of thromboembolic disease, estrogen‑dependent tumors (e.g., breast cancer), active liver disease, uncontrolled hypertension, smokers over 35 years of age, or those who are currently pregnant or breastfeeding. A thorough medical assessment is required before initiation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT